Product Information
INDAPAMIDE 2.5 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1113 per EA under NDC 00228257111. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2.5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228257111
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
INDAPAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074722On Market Since
1/2/2007
Pharmacological Classes
Price Statistics
The NADAC for INDAPAMIDE 2.5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1113 per EA |
|---|---|
| All-time high | $0.3632 (Apr 13, 2016) |
| All-time low | $0.0899 (Nov 20, 2024) |
| 52-week high | $0.1202 |
| 52-week low | $0.1030 |
| Median price | $0.1677 |
| Average price | $0.1881 |
| Largest weekly change | +89.4% (Jul 23, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INDAPAMIDE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INDAPAMIDE 2.5 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1113 per EA (NDC 00228257111), effective Jun 24, 2026.
How has the price of INDAPAMIDE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for INDAPAMIDE 2.5 MG TABLET has risen 8.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INDAPAMIDE 2.5 MG TABLET?
Since Nov 28, 2013, the NADAC for INDAPAMIDE 2.5 MG TABLET has ranged from a low of $0.0899 (Nov 20, 2024) to a high of $0.3632 (Apr 13, 2016), with a median of $0.1677 per EA.
Are there cheaper alternatives to INDAPAMIDE 2.5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as INDAPAMIDE 2.5 MG TABLET, but none are currently priced below it.
Who manufactures INDAPAMIDE 2.5 MG TABLET?
INDAPAMIDE 2.5 MG TABLET (NDC 00228257111) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification